Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Other Accumulated Expenses (2018 - 2025)

Avai Bio's Other Accumulated Expenses history spans 6 years, with the latest figure at $406777.0 for Q1 2024.

  • On a quarterly basis, Other Accumulated Expenses rose 66.56% to $406777.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $406777.0, a 66.56% increase, with the full-year FY2024 number at $406777.0, up 66.56% from a year prior.
  • Other Accumulated Expenses hit $406777.0 in Q1 2024 for Avai Bio, up from $244218.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for AVAI hit a ceiling of $968356.0 in Q4 2020 and a floor of $2816.0 in Q1 2022.
  • Historically, Other Accumulated Expenses has averaged $452054.4 across 4 years, with a median of $457657.0 in 2020.
  • Biggest five-year swings in Other Accumulated Expenses: soared 8572.51% in 2023 and later skyrocketed 66.56% in 2024.
  • Tracing AVAI's Other Accumulated Expenses over 4 years: stood at $968356.0 in 2020, then plummeted by 99.71% to $2816.0 in 2022, then soared by 8572.51% to $244218.0 in 2023, then surged by 66.56% to $406777.0 in 2024.
  • Business Quant data shows Other Accumulated Expenses for AVAI at $406777.0 in Q1 2024, $244218.0 in Q1 2023, and $2816.0 in Q1 2022.